Glutamine Supplementation as an Anticancer Strategy: A Potential Therapeutic Alternative to the Convention

Hayato Muranaka,Rasaq Akinsola,Sandrine Billet,Stephen J. Pandol,Andrew E. Hendifar,Neil A. Bhowmick,Jun Gong

DOI: https://doi.org/10.3390/cancers16051057

2024-03-06

Cancers

Abstract:Glutamine, a multifaceted nonessential/conditionally essential amino acid integral to cellular metabolism and immune function, holds pivotal importance in the landscape of cancer therapy. This review delves into the intricate dynamics surrounding both glutamine antagonism strategies and glutamine supplementation within the context of cancer treatment, emphasizing the critical role of glutamine metabolism in cancer progression and therapy. Glutamine antagonism, aiming to disrupt tumor growth by targeting critical metabolic pathways, is challenged by the adaptive nature of cancer cells and the complex metabolic microenvironment, potentially compromising its therapeutic efficacy. In contrast, glutamine supplementation supports immune function, improves gut integrity, alleviates treatment-related toxicities, and improves patient well-being. Moreover, recent studies highlighted its contributions to epigenetic regulation within cancer cells and its potential to bolster anti-cancer immune functions. However, glutamine implementation necessitates careful consideration of potential interactions with ongoing treatment regimens and the delicate equilibrium between supporting normal cellular function and promoting tumorigenesis. By critically assessing the implications of both glutamine antagonism strategies and glutamine supplementation, this review aims to offer comprehensive insights into potential therapeutic strategies targeting glutamine metabolism for effective cancer management.

oncology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the potential applications of glutamine (Gln) in cancer treatment, especially the possibilities as an anti - tumor strategy. Specifically, the paper focuses on the following aspects:

1. **Glutamine Antagonist Strategy**: The paper discusses methods of inhibiting tumor growth by blocking the glutamine metabolic pathway, such as inhibiting glutamine transporters or glutaminase (GLS). However, due to the complex adaptive metabolic dynamics of cancer cells, these strategies may not provide long - lasting treatment effects.

2. **The Role of Glutamine Supplements**: The paper explores the potential of glutamine supplements in supporting immune function, improving gut integrity, reducing treatment - related toxicity, and improving the quality of life of patients. Nevertheless, there are also some challenges in the application of glutamine supplements, such as the optimal dose, potential interactions with existing treatment regimens, personalized approaches for specific cancer subtypes, and selection of appropriate patient groups.

3. **Regulatory Mechanisms of Glutamine Metabolism**: The paper analyzes in detail the regulatory mechanisms of glutamine metabolism in cancer cells, including how the activities of key enzymes (such as glutaminase, glutamine synthetase, and glutamine transporters) are affected by multiple oncogenes and tumor suppressor genes (such as KRAS, MYC, PI3KCA, p53, and RB). These regulatory mechanisms are crucial for the proliferation, survival, and adaptation of cancer cells to the tumor microenvironment.

4. **Glutamine Concentration in the Tumor Microenvironment**: The paper also discusses the changes in glutamine concentration in the tumor microenvironment and their effects on the functions of cancer cells and immune cells. For example, the glutamine level in the tumor core area is usually low, which may lead to the inhibition of histone demethylation and the impairment of immune cell function.

5. **Clinical Applications of Glutamine Deprivation Strategies**: The paper summarizes a variety of treatment strategies targeting glutamine metabolism in recent years, including glutamine analogs, glutamine transporter blockers, glutaminase inhibitors, glutamine depleters, and targeted interventions in downstream metabolic pathways. Although these strategies have shown potential in pre - clinical studies, their clinical translation still faces many challenges.

Overall, this paper aims to comprehensively evaluate the potential applications of glutamine metabolism in cancer treatment and propose directions for future research, in the hope of developing more effective personalized treatment strategies.